KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $715,372 | -0.7% | 6,167 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $720,484 | +23.2% | 6,137 | -16.0% | 0.00% | +100.0% |
| Q1 2023 | $584,998 | +1.1% | 7,307 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $578,861 | +7.4% | 7,307 | -5.4% | 0.00% | 0.0% |
| Q3 2022 | $539,000 | -6.6% | 7,727 | -12.1% | 0.00% | 0.0% |
| Q2 2022 | $577,000 | -1.2% | 8,787 | +0.1% | 0.00% | 0.0% |
| Q1 2022 | $584,000 | -4.9% | 8,777 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $614,000 | +34.1% | 8,777 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $458,000 | -23.3% | 8,777 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $597,000 | +101.0% | 8,777 | +127.4% | 0.00% | 0.0% |
| Q1 2021 | $297,000 | +31.4% | 3,860 | +2.7% | 0.00% | – |
| Q4 2020 | $226,000 | – | 3,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 1,896,645 | $150,252,217 | 6.15% |
| S Squared Technology, LLC | 108,215 | $8,572,792 | 5.80% |
| Frazier Life Sciences Management, L.P. | 999,737 | $79,199,165 | 4.92% |
| First Light Asset Management, LLC | 473,691 | $37,525,801 | 3.48% |
| Ikarian Capital, LLC | 165,900 | $13,142,598 | 3.17% |
| Soleus Capital Management, L.P. | 188,217 | $14,910,551 | 2.14% |
| Integral Health Asset Management, LLC | 115,000 | $9,110,300 | 1.91% |
| Nicholas Investment Partners, LP | 267,089 | $21,158,791 | 1.85% |
| Artal Group S.A. | 400,000 | $31,688 | 1.77% |
| Avoro Capital Advisors LLC | 1,410,000 | $111,700,200 | 1.67% |